Skip to content

The Effect of Intrathecal Betamethasone on Post Operative Pain Relief after Cesarean Section.

The Effect of Intrathecal Betamethasone on Post Operative Pain Relief after Cesarean Section in Mosavi Hospital.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT201012115363N1
Enrollment
99
Registered
2011-01-28
Start date
2009-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post operative pain. Acute pain

Interventions

Intervention 1: Group 2 (IT): Visual analogue scale for pain was explained to all patients during the preoperative visit. In the operating room routine monitors were established (electrocardiogram, no
Treatment - Drugs
Group 2 (IT): Visual analogue scale for pain was explained to all patients during the preoperative visit. In the operating room routine monitors were established (electrocardiogram, non-invasive blood
Group 1 (Control): Visual analogue scale for pain was explained to all patients during the preoperative visit. In the operating room, routine monitors were established (electrocardiogram, non-invasive
Group 3 (IV): Visual analogue scale for pain was explained to all patients during the preoperative visit. In the operating room routine monitors were established (electrocardiogram, non-invasive blood

Sponsors

Vice- Chancellor for Research of Zanjan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: ASA class I and II, age between 20 and 40 years old, scheduled to undergo Cesarean Section Exclusion criteria: Receiving analgesics or corticosteroids drugs, presence of contraindication to regional anesthesia, known hypersensitivity to the study drugs or if having any history of cardiac, respiratory, neuromuscular, Hepatic or renal disease, unwilling to participate

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of pain. Timepoint: 4, 6, 12, 24 h after operation. Method of measurement: VAS-consisting of 100 mm line with 0 = no pain and 100 = worst possible pain.

Secondary

MeasureTime frame
Number of used suppository. Timepoint: 24 hrs after surgery. Method of measurement: Asking from Patient.;Nausea and vomiting intraoperatively. Timepoint: At the end of the surgery. Method of measurement: Asking from Patient.;Nausea and vomiting postoperatively. Timepoint: 24 hrs after surgery. Method of measurement: Asking from Patient.;Headache after surgery. Timepoint: 24 hrs after surgery. Method of measurement: Asking from Patient.;Time to rescue analgesic drug for the first time. Timepoint: Whenever the VAS goes higher than 4. Method of measurement: Asking from Patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Faramarz Dobakhti

Zanjan University of Medical Sciences

fdobakhti@zums.ac.ir+98 24 1427 3636

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026